ARROWHEAD PHARMACEUTICALS, INC. - 8-K Filing
Arrowhead Pharmaceuticals refinances $400 million senior secured term loan with Sixth Street, securing lower interest rates and eliminating revenue sweeps. (Items: 1.01 Entry into a Material Definitive Agreement, 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant)
Tickers: $ARWR